{"meta":{"query_hash":"b353ce4e93bc","filters":{"venue":"Clinical Proteomics and Bioinformatics"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b353ce4e93bc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Proteomics+and+Bioinformatics"},"results":[{"id":"W2802334461","doi":"10.15761/cpb.1000119","title":"Antibody microarray and immunoblotting analyses of the EGF signaling phosphorylation network in human A431 epidermoid carcinoma cells","year":2017,"lang":"en","type":"article","venue":"Clinical Proteomics and Bioinformatics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"A431 cells; Phosphorylation; Epidermoid carcinoma; Antibody; Cancer research; Biology; Carcinoma; Epidermal growth factor; Pathology; Medicine; Immunology; Cancer; Receptor; Cell biology; Molecular medicine; Genetics","score_opus":0.11968787697014388,"score_gpt":0.4536997581995993,"score_spread":0.3340118812294554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802334461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638061,0.0015686447,0.025083238,0.00025721206,0.000107114414,0.00012181836,0.004244511,0.00037404257,0.004437299],"genre_scores_gemma":[0.9085432,0.0030513955,0.06992769,0.00037812378,0.000054944136,0.0006069244,0.009808336,0.00008175051,0.0075477227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978954,0.000025022566,0.000025828343,0.00006290048,0.00006232623,0.000034365858],"domain_scores_gemma":[0.9999181,0.000018346274,0.000011497833,0.000010108207,0.00003206211,0.000009921681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020394784,0.00026060178,0.00028005286,0.0007026185,0.0003288337,0.00021952367,0.00020528995,0.00027933368,0.001430807],"category_scores_gemma":[0.0001137122,0.00018381332,0.00032825646,0.0007878401,0.000100734746,0.00016860002,0.000099421144,0.00036682465,0.00047342223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044124317,0.000016340764,0.00017899823,0.000027610658,0.000005798353,0.000024995803,0.000013708201,0.00005740299,0.99885356,0.000042800417,0.00006484444,0.0006697247],"study_design_scores_gemma":[0.000017075276,0.00026649414,0.053786125,0.000008420144,0.0000655038,0.00042884742,0.00010995976,0.00520999,0.9353202,0.0001410587,0.0046322304,0.000014156061],"about_ca_topic_score_codex":0.00079986145,"about_ca_topic_score_gemma":0.001453871,"teacher_disagreement_score":0.001430807,"about_ca_system_score_codex":0.00021455095,"about_ca_system_score_gemma":0.00015237293,"threshold_uncertainty_score":0.004786551},"labels":[],"label_agreement":null}]}